PRELUDE CAPITAL MANAGEMENT, LLC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$183,000
-48.6%
68,900
-29.7%
0.01%
-44.4%
Q3 2021$356,000
-16.2%
98,0000.0%0.01%
-30.8%
Q2 2021$425,000
+46.0%
98,000
+15.3%
0.01%
+85.7%
Q1 2021$291,000
-2.3%
85,0000.0%0.01%
-12.5%
Q4 2020$298,000
+46.1%
85,0000.0%0.01%
-20.0%
Q3 2020$204,000
+85.5%
85,000
+41.7%
0.01%
+66.7%
Q2 2020$110,000
+1000.0%
60,000
+1160.5%
0.01%
Q4 2019$10,0000.0%4,760
-13.6%
0.00%
Q3 2019$10,000
-60.0%
5,508
-42.3%
0.00%
-100.0%
Q2 2019$25,000
+47.1%
9,545
+48.5%
0.00%0.0%
Q1 2019$17,0000.0%6,426
-13.6%
0.00%0.0%
Q4 2018$17,000
-22.7%
7,440
+8.1%
0.00%0.0%
Q3 2018$22,000
+22.2%
6,880
+9.7%
0.00%0.0%
Q2 2018$18,000
-14.3%
6,270
+6.0%
0.00%
-50.0%
Q1 2018$21,000
-4.5%
5,913
+5.2%
0.00%0.0%
Q4 2017$22,000
-15.4%
5,619
-42.0%
0.00%0.0%
Q2 2017$26,000
+62.5%
9,691
+101.9%
0.00%0.0%
Q1 2017$16,000
+1500.0%
4,800
+1100.0%
0.00%
Q4 2016$1,000
-94.1%
400
-91.1%
0.00%
-100.0%
Q3 2016$17,000
-73.8%
4,500
-84.5%
0.00%
-77.8%
Q2 2016$65,000
+25.0%
29,000
+16.5%
0.01%
+28.6%
Q1 2016$52,000
-17.5%
24,900
+20.3%
0.01%
-30.0%
Q4 2015$63,000
-14.9%
20,700
-31.1%
0.01%
-9.1%
Q3 2015$74,000
+393.3%
30,046
+532.5%
0.01%
+450.0%
Q2 2015$15,0004,7500.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders